Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes

Canada News News

Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
Canada Latest News,Canada Headlines
  • 📰 SaltWire Network
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 63%

Explore stories from Atlantic Canada.

Halifax Regional Police release Dartmouth suspect’s name and photo | SaltWire #news #novascotiaCOPENHAGEN - Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing so-called GLP-1 drugs such as Novo Nordisk's Ozempic, the Danish Medicines Agency said on Wednesday.

Doctors and other prescribers in the UK were in July ordered to stop prescribing Ozempic to people who don't have type 2 diabetes, following a national shortage of GLP-1 drugs due to the soaring demand for approved and off-label use.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

SaltWire Network /  🏆 45. in CA

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Ozempic Subsidies Cut in Novo Nordisk’s Home Country of DenmarkOzempic Subsidies Cut in Novo Nordisk’s Home Country of DenmarkSubsidies for Ozempic will be restricted in Novo Nordisk A/S’s home country of Denmark due to rising public spending on the blockbuster diabetes medicine, which is increasingly being used as a weight-loss treatment.
Read more »

Ozempic ‘Oops’ Babies Spark Debate About Weight-Loss Shot Use as Fertility DrugsOzempic ‘Oops’ Babies Spark Debate About Weight-Loss Shot Use as Fertility DrugsA surprising thing is happening to some women on weight-loss drugs who’ve struggled with fertility issues: They’re getting pregnant. That’s leading to questions about the safety of medications from Novo Nordisk A/S and Eli Lilly & Co. during pregnancy.
Read more »

US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competitionUS challenges 'bogus' patents on Ozempic and other drugs in effort to spur competitionWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest...
Read more »

US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competitionUS challenges 'bogus' patents on Ozempic and other drugs in effort to spur competitionFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic, in the latest effort by the Biden administration targeting pharmaceutical industry practices that drive up prices.
Read more »

No link between Ozempic, Wegovy and suicide, EU drug regulators sayNo link between Ozempic, Wegovy and suicide, EU drug regulators sayDrug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked to a higher risk of suicidal ...
Read more »

The Canadian doctor who helped invent OzempicThe Canadian doctor who helped invent OzempicDecades ago, Toronto researcher Daniel Drucker co-discovered a hormone that paved the way for today's most-talked-about drug. Does he get the hype? Yes and no.
Read more »



Render Time: 2025-02-22 13:14:41